Article
A circulating tumor cell-based digital assay for the detection of EGFR T790M mutation in advanced non-small cell lung cancer.
Journal of materials chemistry. B - 8 Jul 2020
Wang Jing, Sun Na, Lee Yi-Te, Ni Yiqian, Koochekpour Rose, Zhu Yazhen, Tseng Hsian-Rong, Wang Shuyang, Jiang Liyan, Zhu Hongguang
Abstract excerpt
Determining the status of epidermal growth factor receptor (EGFR) T790M mutation is crucial for guiding further treatment intervention in advanced non-small cell lung cancer (NSCLC) patients who develop acquired resistance to initial EGFR tyrosine kinase inhibitor (TKI) treatment. Circulating tumor cells (CTCs) which contain plentiful copies of well-preserved RNA offer an ideal source for noninvasive detection of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
